These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31088113)

  • 1. Late diagnosis of hypophosphatasia in a case with Unverricht-Lundborg disease.
    Zouwail S; Longworth N; Grey J; Nesbitt M; Sisodiya S; Hamandi K
    Ann Clin Biochem; 2019 Jul; 56(4):515-518. PubMed ID: 31088113
    [No Abstract]   [Full Text] [Related]  

  • 2. Unverricht-Lundborg disease (EPM1).
    Genton P
    Epilepsia; 2010 Feb; 51 Suppl 1():37-9. PubMed ID: 20331711
    [No Abstract]   [Full Text] [Related]  

  • 3. Marked response to perampanel: A decade-long course of giant somatosensory evoked potentials in Unverricht-Lundborg disease.
    Tojima M; Takahashi R; Neshige S; Hitomi T; Matsuhashi M; Ikeda A
    Clin Neurophysiol; 2021 Oct; 132(10):2329-2331. PubMed ID: 34454258
    [No Abstract]   [Full Text] [Related]  

  • 4. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
    Kim KH; Song JS; Park CW; Ki CS; Heo K
    Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perampanel in 12 patients with Unverricht-Lundborg disease.
    Crespel A; Gelisse P; Tang NP; Genton P
    Epilepsia; 2017 Apr; 58(4):543-547. PubMed ID: 28166365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot open-label trial of zonisamide in Unverricht-Lundborg disease.
    Italiano D; Pezzella M; Coppola A; Magaudda A; Ferlazzo E; Bramanti P; Striano S; Zara F; Striano P
    Mov Disord; 2011 Feb; 26(2):341-3. PubMed ID: 20939070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic drug intervention decouples electroencephalogram (EEG) signals: a case study in Unverricht-Lundborg Disease.
    Liu CC; Xanthopoulos P; Chaovalitwongse W; Pardalos PM; Uthman BM
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():2108-11. PubMed ID: 19163112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unverricht-Lundborg disease with cystatin B gene abnormalities.
    Kagitani-Shimono K; Imai K; Okamoto N; Ono J; Okada S
    Pediatr Neurol; 2002 Jan; 26(1):55-60. PubMed ID: 11814737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T2-weighted high-intensity signals in the basal ganglia as an interesting image finding in Unverricht-Lundborg disease.
    Korja M; Ferlazzo E; Soilu-Hänninen M; Magaudda A; Marttila R; Genton P; Parkkola R
    Epilepsy Res; 2010 Jan; 88(1):87-91. PubMed ID: 19896804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waveform window #27. A trip to the Baltic.
    Cheng-Hakimian A
    Neurodiagn J; 2014 Jun; 54(2):187-92. PubMed ID: 25080777
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term evolution of EEG in Unverricht-Lundborg disease.
    Gargouri-Berrechid A; Nasri A; Kacem I; Sidhom Y; Abdelkefi I; Hizem Y; Ben Djebrara M; Gouider R
    Neurophysiol Clin; 2016 Apr; 46(2):119-24. PubMed ID: 27157382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.
    Genton P; Gelisse P; Crespel A
    Epilepsia; 2006 Dec; 47(12):2083-5. PubMed ID: 17201707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type.
    Smith B; Shatz R; Elisevich K; Bespalova IN; Burmeister M
    Epilepsia; 2000 Aug; 41(8):1046-8. PubMed ID: 10961635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein aggregation as a possible cause for pathology in a subset of familial Unverricht-Lundborg disease.
    Ceru S; Rabzelj S; Kopitar-Jerala N; Turk V; Zerovnik E
    Med Hypotheses; 2005; 64(5):955-9. PubMed ID: 15780491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.
    Magaudda A; Gelisse P; Genton P
    Epilepsia; 2004 Jun; 45(6):678-81. PubMed ID: 15144434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine and Unverricht-Lundborg disease: variable response and possible side effects.
    Edwards MJ; Hargreaves IP; Heales SJ; Jones SJ; Ramachandran V; Bhatia KP; Sisodiya S
    Neurology; 2002 Nov; 59(9):1447-9. PubMed ID: 12427904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-dose perampanel improved cortical myoclonus and basophobia in a patient with Unverricht-Lundborg disease: a case report].
    Oi Y; Kobayashi K; Hitomi T; Matsumoto R; Ikeda A; Takahashi R
    Rinsho Shinkeigaku; 2018 Oct; 58(10):622-625. PubMed ID: 30270337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difficult differential diagnosis of Unverricht-Lundborg disease with spontaneous kinesogenic myoclonus and movement disorder.
    Rana AQ; Ali A; Böke BN
    Acta Neurol Belg; 2012 Dec; 112(4):383-4. PubMed ID: 22539245
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteomalacia with low alkaline phosphatase: a not so rare condition with important consequences.
    Belkhouribchia J; Bravenboer B; Meuwissen M; Velkeniers B
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26823351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unverricht-Lundborg disease: Clinical course and seizure management based on the experience of polish centers.
    Lasek-Bal A; Lukasik M; Żak A; Sulek A; Bosak M
    Seizure; 2019 Jul; 69():87-91. PubMed ID: 30999254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.